Menu

Experience

Matt Browne

    • Shoreline Biosciences Closes $140 Million Funding 


    • Sixth Street Invests in Blueprint Medicines 


    • Billtrust to Combine With South Mountain, a Special Purpose Acquisition Company, at $1.3 Billion Value 


    • Oberland Capital in financing of Agenus 


    • AcelRx sale of Zalviso® royalties to PDL BioPharma  


    • Renovate America Series F financing  


    • TPG Special Situations Partners purchase of Kadcyla® royalties from ImmunoGen  


    • Volcano Corp. Acquired by Royal Philips NV for $1.2 Billion 


    • Volcano Acquired by Philips for $1.2 Billion 


    • Insys Therapeutics IPO